Rekombinanter MLANA Antikörper (full length)
Kurzübersicht für Rekombinanter MLANA Antikörper (full length) (ABIN7477517)
Target
Alle MLANA Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- Melan A CR (Cross Reactive) antibody (901M+)
-
Immunogen
- Recombinant full-length hMART-1 protein
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- IHC 1:50-1:100
-
Kommentare
-
Positive Control: Skin: Virtually all melanocytes should show a strong Melan A+ immunostaining including a weak to moderate staining in melanocytic dendrites. Adrenal gland: An at least moderate Melan A+ immunostaining should be seen in adrenocortical cells.
Product Description/Background: Melan A antibody validated for immunohistochemistry on 76 different Normal Tissues
Negative Control: Kidney: Melan A immunostaining should be absent in all cells. Adrenal gland: Melan A+ immunostaining should be absent in all medullary cells.
-
Protokoll
- Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:75 at 37 °C for 60 minutes.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8 C. Antibody without azide - store at -20 to -80 C. Antibody is stable for 24 months. Non- hazardous. No MSD required.
-
Haltbarkeit
- 24 months
-
-
- MLANA (Melan A (MLANA))
-
Andere Bezeichnung
- MLANA
-
Hintergrund
- Gene Alias: Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA
-
UniProt
- Q16655
Target
-